Phase I dose escalation study of pegylated liposomal doxorubicin (Caelyx) in combination with topotecan in patients with advanced malignancies.

Source:http://linkedlifedata.com/resource/pubmed/id/16763786

Download in:

View as

General Info

PMID
16763786